Patents by Inventor Kathe Lynn Stauber

Kathe Lynn Stauber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240058350
    Abstract: Provided are methods for the parenteral use of 3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide, or a pharmaceutically acceptable salt, hydrate, or solvate thereof, and the sequential use of parenteral and oral formulations of 3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide, or a pharmaceutically acceptable salt, hydrate, or solvate thereof.
    Type: Application
    Filed: December 30, 2021
    Publication date: February 22, 2024
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: John William Adams, Prodromos Anthopoulos, Kathe Lynn Stauber, Brandon James Walsh